If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.025 (11.11%)
Bid:
0.20
Ask:
0.30
Spread: 0.10 (50.00%)
Market Cap: £1.31m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

19 Jun 2008 09:46

RNS Number : 0703X
UBS AG (EPT)
19 June 2008
 

FORM 38.5(b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

 

 

1. KEY INFORMATION

 

Name of exempt principal trader

UBS AG London Branch

Company dealt in

Expro International Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

10p Ordinary

Date of dealing

18 JUNE 2008

 

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of 

relevant security dealt in (Note 2)

 

 

Long

 

Short

 

 

Number

(%)

Number 

(%)

(1) Relevant securities 

14,900

0.01%

388

0.00%

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

14,900

0.01%

388

0.00%

(b) Interests and short positions in relevant securities of

the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

 

Short

 

 

Number 

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

Rights to subscribe (Note 2)

Class of relevant security:

Details

3. DEALINGS (Note 3)

 (a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 4)

SALE

528

1659 pence

SALE

23

1659

SALE

22

1660

PURCHASE

13

1660

PURCHASE

37

1660

PURCHASE

80

1660

PURCHASE

100

1660

PURCHASE

108

1660

PURCHASE

202

1660

PURCHASE

205

1660

PURCHASE

284

1660

PURCHASE

287

1660

PURCHASE

342

1660

PURCHASE

600

1660

PURCHASE

1237

1660

SALE

15

1661

PURCHASE

59

1661

PURCHASE

100

1661

PURCHASE

145

1661

PURCHASE

495

1661

PURCHASE

1266

1661

SALE

20

1662

PURCHASE

15

1662

PURCHASE

89

1662

PURCHASE

148

1662

PURCHASE

169

1662

PURCHASE

170

1662

PURCHASE

200

1662

PURCHASE

243

1662

PURCHASE

467

1662

PURCHASE

513

1662

SALE

258

1663

SALE

200

1663

SALE

50

1663

PURCHASE

50

1663

PURCHASE

80

1663

PURCHASE

160

1663

PURCHASE

198

1663

PURCHASE

251

1663

PURCHASE

484

1663

PURCHASE

600

1663

PURCHASE

974

1663

SALE

500

1664

SALE

84

1664

PURCHASE

200

1664

PURCHASE

321

1664

SALE

1843

1665

SALE

709

1665

SALE

317

1665

SALE

661

1666

SALE

404

1666

SALE

202

1666

SALE

100

1666

SALE

20

1667

SALE

800

1668

SALE

400

1668

SALE

117

1668

SALE

54

1668

PURCHASE

399

1668

PURCHASE

38

1669

PURCHASE

69

1669

PURCHASE

377

1669

PURCHASE

1050

1669

TOTAL PURCHASES

12,825

TOTAL SALES

7,327

(b) Derivatives transactions (other than options)

Product name, e.g CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling, purchasing, varying etc

Number of securities to which the option relates (Note 6)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 4)

 

(d) Other dealings (including new securities) (Note 3)

 

Nature of transaction(Note 7)

Details

Price per unit (if applicable)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

……………………………………………………………………

 

……………………………………………………………………

 

Is a Supplemental Form 38.5(b) attached? (Note 8) NO

 

Date of disclosure

19 JUNE 2008

Contact name

LOUISE ROBINSON

Telephone number

020 7567 8762

Name of offeree/offeror with which connected

Halliburton Company

Nature of connection (Note 9)

CONNECTED ADVISER

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMGIGDLUSBGGIC
Date   Source Headline
2nd Mar 20077:30 amRNSDisposal
22nd Feb 20074:45 pmRNSHolding(s) in Company
20th Feb 20074:14 pmRNSHolding(s) in Company
31st Jan 20074:00 pmRNSTotal Voting Rights
29th Jan 20078:40 amRNSHolding(s) in Company
19th Jan 20074:00 pmRNSTotal Voting Rights
15th Jan 20074:28 pmRNSHolding(s) in Company
10th Jan 20072:24 pmRNSHolding(s) in Company
4th Jan 200712:29 pmRNSHolding(s) in Company
29th Dec 20067:00 amRNSTotal Voting Rights
20th Dec 20068:27 amRNSDirectorate Change
7th Dec 20065:19 pmRNSHolding(s) in Company
30th Nov 20066:15 pmRNSResults of Secondary Placing
30th Nov 20065:56 pmRNSAcquisition
30th Nov 20065:52 pmRNSOrdinary share placing
30th Nov 20067:00 amRNSInterim Results
23rd Nov 20065:20 pmRNSHolding(s) in Company
14th Nov 20062:13 pmRNSHolding(s) in Company
3rd Nov 200610:57 amRNSNotice of Results
29th Sep 20065:12 pmRNSDirector/PDMR Shareholding
27th Sep 20064:39 pmRNSDirector/PDMR Shareholding
25th Sep 20067:01 amRNSTrading Statement
19th Sep 20067:01 amRNSInvestor Visit
14th Sep 20064:52 pmRNSDirector/PDMR Shareholding
5th Sep 20063:31 pmRNSHolding(s) in Company
21st Aug 20063:34 pmRNSBlocklisting Interim Review
1st Aug 20063:14 pmRNSHolding(s) in Company
1st Aug 20067:00 amRNSCompletion of Acquisition
26th Jul 200610:03 amRNSResults of Rights Issue
24th Jul 20067:01 amRNSAntitrust Approvals
19th Jul 20065:54 pmRNSDirector/PDMR Shareholding
19th Jul 20065:50 pmRNSDirector/PDMR Shareholding
14th Jul 20064:07 pmRNSHolding(s) in Company
10th Jul 20064:22 pmRNSDirector/PDMR Shareholding
10th Jul 20064:22 pmRNSDirector/PDMR Shareholding
10th Jul 20064:20 pmRNSDirector/PDMR Shareholding
10th Jul 20064:19 pmRNSDirector/PDMR Shareholding
10th Jul 20064:17 pmRNSHolding(s) in Company
10th Jul 20064:16 pmRNSHolding(s) in Company
4th Jul 20068:44 amRNSAdmission of Nil Paid Rights
3rd Jul 20064:09 pmRNSResult of EGM
30th Jun 200612:21 pmRNSHolding(s) in Company
27th Jun 20066:09 pmRNSAnnual Information Update
14th Jun 20065:39 pmRNSProspectus and Circular
14th Jun 20067:38 amRNSAcquisition
8th Jun 20064:29 pmRNSAnnual Report and Accounts
2nd Jun 20069:00 amRNSInvestor Visit
31st May 20067:02 amRNSFinal Results - Part 2
31st May 20067:02 amRNSRe Contract
31st May 20067:02 amRNSFinal Results - Part 1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.